-
Founded in:
1985-03-15 -
Country:
China -
Address:
No. 75, Ehuang Road, Huangshi City -
Tax NO.:
914202007809444236 -
Registered Funds:
25.69 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Procadilol Hydrochloride |
1. It has obvious bronchodilator effect; 2. The duration of bronchodilator effect is longer than that of other similar drugs; 3. It has superior selectivity for beta 2-receptors; 4. It has anti-allergic effect and can inhibit immediate and delayed increase in airway reactivity; 5. It promotes respiratory cilia movement and increases respiratory defense ability; 6. It may prevent or alleviate the occurrence of exercise-induced asthma.
More
1. It has obvious bronchodilator effect; 2. The duration of bronchodilator effect is longer than that of other similar drugs; 3. It has superior selectivity for beta 2-receptors; 4. It has anti-allergic effect and can inhibit immediate and delayed increase in airway reactivity; 5. It promotes respiratory cilia movement and increases respiratory defense ability; 6. It may prevent or alleviate the occurrence of exercise-induced asthma. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Organic Calcium Boron Zinc |
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis
More
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis |
0 | ||
| Phosphorus |
Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis
More
Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis |
7723-14-0 | 0 | |
| Inorganic perovskite quantum dots CSPBX3 (X is CL, BR, I halogen) |
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis
More
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis |
0 | ||
| Inorganic salt |
Participates in the regulation of bone metabolism
More
Participates in the regulation of bone metabolism |
0 | ||
| Trace Elements |
Participate in the regulation of bone metabolism and prevent and treat osteoporosis
More
Participate in the regulation of bone metabolism and prevent and treat osteoporosis |
0 | ||
| L-tert-Leucine |
Participate in the regulation of bone metabolism and stimulate osteoblast proliferation
More
Participate in the regulation of bone metabolism and stimulate osteoblast proliferation |
20859-02-3 | 0 | |
| Active peptides for bone metabolism |
Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic
More
Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lincomycin hydrochloride |
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.
More
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria. |
859-18-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lidocaine hydrochloride |
This product is an amide local anesthetic, which has a biphasic effect of excitation and inhibition on the central nervous system. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and has an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction and myocardial contraction; when the blood drug concentration is further increased, it can cause a slowing of heart conduction velocity, atrioventricular conduction block, inhibit myocardial contractility and reduce cardiac output.
More
This product is an amide local anesthetic, which has a biphasic effect of excitation and inhibition on the central nervous system. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and has an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction and myocardial contraction; when the blood drug concentration is further increased, it can cause a slowing of heart conduction velocity, atrioventricular conduction block, inhibit myocardial contractility and reduce cardiac output. |
6108-05-0 | 45 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dehydroandrographolide |
|
134418-28-3 | 0 | |
| D-(-)-Tartaric Acid |
|
147-71-7 | 1 |